4//SEC Filing
Bell John K 4
Accession 0001213900-17-012293
CIK 0001498382other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:32 PM ET
Size
7.3 KB
Accession
0001213900-17-012293
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Purchase
Common Stock
2017-11-15$0.81/sh+1,871$1,516→ 76,890 total(indirect: See footnote) - Purchase
Common Stock
2017-11-16$0.81/sh+18,129$14,684→ 95,019 total(indirect: See footnote)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.7997 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $0.8086 to $0.81. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Shares are held by Onbelay Capital Inc.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001569585
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:32 PM ET
- Size
- 7.3 KB